微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.92% | 4.26% | 24.84% | 74/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.14% | 41.44% | 139.69% | 63/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.31% | 32.32% | -70.43% | 82/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.43% | 0.45% | 17.82% | 68/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.76% | -10.69% | 69.37% | 84/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.22% | -28.16% | 124.24% | 82/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.99% | -23.85% | -77.55% | 95/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.41% | -40% | 4.75% | 80/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.21% | -54.19% | 36.25% | 72/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.09% | -53.04% | 137.69% | 66/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.3% | 2% | -82.31% | 79/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.35% | -65.03% | -20.02% | 65/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.19% | 2% | 39.67% | 40/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.58% | -35.55% | -68.7% | 35/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 21.02% | 8.86% | 105.88% | 20/160 | 3.74% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 10.21% | 2% | -47.13% | 17/160 | 4.24% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | 19.31% | 28.73% | 28.73% | 22/160 | 2.78% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 15% | 46.48% | 46.48% | 32/160 | 7.09% | 河化股份 | 45.32% | 行业排名> |
| 2017-12-31 | 10.24% | 2% | 2% | 49/160 | 9.66% | 汇宇制药 | 31.9% | 行业排名> |